Given that Texprog cells but not Texterm cells can respond to anti-PD-1 therapy, we treated tumor-bearing Id2fl/flCd4-Cre− mice and Id2fl/flCd4-Cre+ mice with an anti-PD-1 antibody [8, 25] (Fig. 6J). Here, PDCD1 is linked to neoplasm.